BIOMAT Database Logo BIOMAT Database Logo

Structural requirements for interaction with the oligopeptide transporter in Caco-2 cells. 1995

I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Molecular modeling study of structural requirements for the oligopeptide transporter.
January 1996, Journal of drug targeting,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Structural characterization of substrates for the anion exchange transporter in Caco-2 cells.
November 1999, Journal of pharmaceutical sciences,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Interaction of oligonucleotide-conjugates with the dipeptide transporter system in Caco-2 cells.
May 1997, Biochemical pharmacology,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Extracellular glucose concentration alters functional activity of the intestinal oligopeptide transporter (PepT-1) in Caco-2 cells.
March 2003, Journal of pharmaceutical sciences,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
July 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Structure-affinity relationships of Val-Val and Val-Val-Val stereoisomers with the apical oligopeptide transporter in human intestinal Caco-2 cells.
January 1998, Journal of drug targeting,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
New methods to evaluate intestinal drug absorption mediated by oligopeptide transporter from in vitro study using Caco-2 cells.
January 2002, Drug metabolism and pharmacokinetics,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
September 1998, The Journal of pharmacology and experimental therapeutics,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
September 2001, Journal of controlled release : official journal of the Controlled Release Society,
I J Hidalgo, and P Bhatnagar, and C P Lee, and J Miller, and G Cucullino, and P L Smith
Effect of charge on oligopeptide transporter-mediated permeation of cyclic dipeptides across Caco-2 cell monolayers.
November 1996, Pharmaceutical research,
Copied contents to your clipboard!